SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001764013-23-000072
Filing Date
2023-06-26
Accepted
2023-06-26 07:26:44
Documents
5
Period of Report
2023-08-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A imvt-20230331defproxy.htm DEF 14A 572801
2 GRAPHIC immunovantinc_prxyxgt20xp9b.jpg GRAPHIC 516918
3 GRAPHIC immunovantinc_prxyxgt20xp9c.jpg GRAPHIC 216757
4 GRAPHIC nlvscap2022-2023a.jpg GRAPHIC 365518
5 GRAPHIC tsrvscap2022-2023a.jpg GRAPHIC 123799
  Complete submission text file 0001764013-23-000072.txt   2257613
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-38906 | Film No.: 231039426
SIC: 2836 Biological Products, (No Diagnostic Substances)